BioLineRx (BLRX) Posts Q1 Loss of 1c/Share

BioLineRx (NASDAQ: BLRX) reported Q1 EPS of ($0.01), $0.05 better than the analyst estimate of ($0.06).

For earnings history and earnings-related data on BioLineRx (BLRX) click here.

You May Also Be Interested In

• Pelagos Insurance Capital (PLGO) PT Raised to $28 at Citizens on Rising Book Value
• UBS sees Cerebras' European expansion as positive for OpenAI deal
• Delta Air Lines Q2 earnings preview: softer profit expected amid fuel price headwinds